WednesdayDec 30, 2020 12:40 pm

Brain Scientific Inc. (BRSF) Launches Latest Version of NeuroCap at Largest Global Conference for Neuro Specialists

BRSF presented a new version of NeuroCap(TM), a revolutionary disposable EEG headset Latest version presented to international medical audience includes velcro enhancements for better adhesion Brain Scientific appears well placed to capitalize on growing need for neurodiagnostic procedures Brain Scientific (OTCQB: BRSF) a neurology-focused medical device company, presented updates on its proprietary brain diagnostics technology at AES2020, the virtual annual meeting of the American Epilepsy Society, the world's largest scientific meeting focused on epilepsy and clinical neurophysiology. BRSF released the latest version of its disposable electroencephalogram (“EEG”) device in October 2020: the NeuroCap with velcro enhancements, which provide better adhesion,…

Continue Reading

TuesdayDec 29, 2020 2:30 pm

Smartphone Cameras Can Now Be Used in Diagnosing Viral Diseases

A group of scientists from a Harvard Medical School teaching hospital, Brigham and Women’s Hospital, has designed a system that uses a smartphone camera to check for disease-causing infections. The study was reported in the “Science Advances” journal. In the paper, the team of researchers explains how the system works. The system requires a smartphone system that utilizes a deep learning algorithm that has been trained and an external catalytic microchip device. The coronavirus pandemic has affected most if not all countries across the globe, with most industries also experiencing the detrimental effects caused by the pandemic. To be better…

Continue Reading

TuesdayDec 29, 2020 11:42 am

Hour of Truth Approaching in CNS Pharmaceuticals (NASDAQ: CNSP) Testing of Drug Candidate Against Deadly Brain Cancer

A novel anthracycline believed to be effective in combatting deadly glioblastoma brain cancers by crossing the blood-brain barrier and zeroing in on the tumor will begin Phase 2 trials during Q1 of next year The drug, Berubicin, is being developed by CNS Pharmaceuticals after initial testing nearly 15 years ago resulted in improvements among some subjects, including one who has survived cancer-free since that time The company, in collaboration with Polish sub-licensee partner WPD Pharmaceuticals, plans a multinational staged series of trials that will attempt to keep time and costs to outcome at a minimum As part of the effort,…

Continue Reading

MondayDec 28, 2020 2:45 pm

Engineers Develop Better Way to Test Wastewater for SARS-CoV-2 Virus

A recent study reported in “Environmental Science & Technology” outlines a procedure that can be used to not only detect the coronavirus in wastewater samples but also track the rate of infection to know whether the levels are moving down or up. Wastewater is a coronavirus source, given that infected individuals discharge the virus through their stool. Testing this wastewater could therefore be utilized in tracking the virus. The information gathered can then be used as supplementary information by public health officials in containing the virus. This may help improve public health measures. This test works by determining and measuring…

Continue Reading

WednesdayDec 23, 2020 12:00 pm

Researchers Disinfect Face Masks Using Industrial Microwaves

Cardiff University researchers have been conducting tests to see whether it is feasible to sterilize personal protective equipment (PPE) used by health practitioners to combat the COVID-19 pandemic using dry heat and microwave ovens. The researchers’ findings were published in the “Journal of Hospital Infection.” The group of researchers demonstrated that some respirators could be sterilized successfully in one and a half minutes using a baby bottle sterilizer that had water and an industrial-grade microwave oven. Jean-Yves Maillard, a professor from Cardiff’s School of Pharmacy and Pharmaceutical Sciences who is also the study’s co-author, explained that the inability of frontline…

Continue Reading

TuesdayDec 22, 2020 1:45 pm

Digital Stethoscope Incorporates AI to Improve Lung Issues Diagnosis

You’ve probably been to the doctor at least once in your life. During your visit, the nurse likely measured your weight, blood pressure and temperature before you saw the doctor. If you had an issue with your chest, the doctor probably listened to the sounds inside your body, made by various organs such as your lungs and heart, using a stethoscope. A stethoscope is an acoustic medical device made for the specific purpose of listening to the internal sounds of a human or animal body. Used by every doctor or health practitioner, the stethoscope is a cost-effective tool that helps…

Continue Reading

TuesdayDec 22, 2020 12:08 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Moving Forward with Clinical Trials in 2021 after Receiving FDA Approval for IND for Berubicin

The company is scheduled to conduct three clinical trials in 2021 for Berubicin – two Phase II and the first-ever Phase I in pediatric patients FDA modified the trial design to designate overall survival as the trial’s primary endpoint The market for brain tumor therapies is expected to grow at a CAGR of 10% and reach an estimated $1.6 billion in 2025 CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, announced that it obtained the Food and Drug Administration’s Investigational New Drug…

Continue Reading

MondayDec 21, 2020 2:15 pm

FDA Approves OTC Coronavirus Home-Sample Collection Kit

Last week, the Food and Drug Administration (FDA) announced that it had approved the first over-the-counter (OTC) home-sample collection kit for the coronavirus. The coronavirus test collection kit — LabCorp Pixel kit — is permitted for use by people aged 18 years and above and can be used without a prescription. The testing kit includes a nasal swab, which will be used to collect a sample at home. The self-collected sample can then be sent out to be tested at LabCorp. Test users will then receive their test results either through an online portal, a phone call from their health-care provider…

Continue Reading

MondayDec 21, 2020 1:01 pm

Predictive Oncology (NASDAQ: POAI) Adjourns Special Virtual Meeting; CEO Requesting Shareholder Vote for Critical Tax-Related Proposal

POAI sent letter to shareholders requesting attendance at virtual Special Meeting on December 30, 2020 Meeting will address reincorporation of POAI in Nevada Reincorporation expected to save POAI approximately $158,000 annually in state taxes Shareholders can vote online or by telephone, detailed instructions outlined in proxy materials Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, recently sent a letter to all shareholders urging them to attend a virtual Special Meeting of Stockholders (the “Meeting”). Originally scheduled for December 1, 2020, the Meeting will be reconvened on December 30, 2020…

Continue Reading

FridayDec 18, 2020 2:45 pm

What Successful Coronavirus Vaccines Should Do

The recent news of the discovery of coronavirus vaccines has been welcomed by many, albeit with accompanying speculations and safety concerns. Generally, it is assumed that when an individual is vaccinated, he or she becomes immune to the disease in question. However, as we do not measure immunity, how will we then know if a person has indeed become immune to a disease after vaccination? Two studies that were published recently in “Science Translational Medicine” look into this by exploring the body’s antibody response to infection, with a focus on the SARS-CoV-2 virus. As a general rule, the body’s antibody…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000